Journal Mobile Options
Table of Contents
Vol. 58, No. 4, 2012
Issue release date: June 2012

Changing Profile of Health and Function from Age 70 to 85 Years

Jacobs J.M. · Maaravi Y. · Cohen A. · Bursztyn M. · Ein-Mor E. · Stessman J.
To view the fulltext, log in and/or choose pay-per-view option

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Background: Old age has traditionally been considered to begin at age 65. The improving health and functional status observed among older people may necessitate reevaluation of this cut-off point. Objective: To present the changing prevalence of common geriatric syndromes, functional parameters, common disease status and health care utilization, at ages 70, 78 and 85, in order to help address the question of when does contemporary aging actually begin. Methods: Medical, psychosocial, cognitive, and functional status, and health service utilization at age 70, 78 and 85 were assessed through the Jerusalem Longitudinal Cohort Study (1990–2010), which prospectively followed a representative sample (born 1920–1921), of 1,861 people, all of whom underwent home-based comprehensive assessment. Results: At age 70, the cohort had good health, low comorbidity, preserved cognition, mobility and independence in basic and instrumental activities of daily activities (ADL). Rising comorbidity, declining cognitive status, increasing depression, and difficulty in ADLs were seen at 78. By age 85, compared to age 70, comorbidity had tripled, depression, hearing and visual impairment, falls, dizziness and mobility problems had doubled; 23% of subjects had cognitive impairment, 42.5% suffered urinary incontinence, and dependence in basic and instrumental ADLs was common (37.8 and 51.7%, respectively). Home care was 4.5, 10.1, and 24.6%, and hospitalization in the previous year occurred among 12.3, 18.8 and 27.8% at ages 70, 78 and 85, respectively. Conclusions: At age 70, the overall health profile was favorable, prevalence of geriatric syndromes was low, cognitive and functional status was preserved, and health service utilization was low. The progressive deterioration seen at ages 78 and more profoundly so at age 85, suggest that a cut-off point beyond age 70 years may serve to better define entry into old age.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Newman AB: An overview of the design, implementation, and analyses of longitudinal studies on aging. J Am Geriatr Soc 2010;58:S287–S291.

    External Resources

  2. Seematter-Bagnoud L, Santos-Eggiman B: Population-based cohorts of the 50s and over: a summary of worldwide previous and ongoing studies for research on health in aging. Eur J Aging 2006;3:41–59.

    External Resources

  3. Nybo H, Gaist D, Jeune B, McGue M, Christensen K: Functional status and self-rated health in 2,262 nonagenarians: the Danish 1905 Cohort Survey. J Am Geriatr Soc 2001;49:601–609.
  4. Collerton J, Davies K, Jagger C, et al: Health and diseases in 85 year olds: baseline findings from the Newcastle 85+ cohort study. BMJ 2009;399:b4904.

    External Resources

  5. Pitkala KH, Valvanne J, Strandberg TE, Tilvis RS: Secular trends in self-reported functioning, needs for assistance and attitudes towards life; 10-year differences of three older cohorts. J Am Geriatr Soc 2001;49:596–600.
  6. Maxson PJ, Berg S, McClearn G: Multidimensional patterns of aging in 70-year-olds: survival differences. J Health 1996;8:320–333.
  7. Meijer WT, Grobbee DE, Hunink MG, Hoffman A, Hoes AW: Determinants of peripheral artery disease in the elderly: the Rotterdam study. Arch Intern Med 2000;160:2934–2938.
  8. Janzon L, Hanson BS, Isacsson SO, Lindell SE, Steen B: Factors influencing participation in health surveys: results from prospective population study ‘Men born in 1914’ in Malmo, Sweden. J Epidemiol Community Health 1986;40:174–177.
  9. Hawranik P: The role of cognitive status in the use of in home services: implication for nursing assessment. Can J Nurs Res 1998;30:45–65.
  10. Westendorp RG: Leiden research program on aging. Exp Gerontol 2002;37:609–614.
  11. Christensen K, Doblhammer G, Rau R, Vaupel JW: Aging populations: the challenges ahead. Lancet 2009;374:1196–1208.
  12. Jacobs JM, Cohen A, Bursztyn M, Azoulay D, Ein-Mor E, Stessman J: Cohort profile: the Jerusalem longitudinal cohort study. Int J Epidemiol 2009;38:1464–1469.

    External Resources

  13. Stessman J, Cohen A, Ginsberg GM, et al: The Jerusalem 70-year-old longitudinal study. I. Description of the initial cross sectional survey. Eur J Epidemiol 1995;11:675–684.
  14. Cohen A, Stessman J, Ginsberg GM, et al: Jerusalem 70-year-old longitudinal study II: Background results from the initial home interview. Eur J Epidemiol 1995;11:685–692.
  15. World Health Organization: International Classification of Diseases, Ninth Revision (ICD-9). Geneva, World Health Organization, 1977.
  16. Charlson ME, Pompei P, Ales KL, et al: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 1987;40:373–383.
  17. Derogatis LR, Melisaratos N: The Brief Symptom Inventory: an introductory report. Psychol Med 1983;13:596–605.

    External Resources

  18. Folstein MF, Folstein SE, McHugh PR: Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–198.
  19. Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW: Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function. JAMA 1963;185:914–919.
  20. Stessman J, Hammerman-Rozenberg R, Maaravi Y, Cohen A: The impact of exercise on ease of performance of ADL and IADL from age 70–77: the Jerusalem longitudinal study. J Am Geriatr Soc 2002;50:1934–1938.
  21. Stessman J, Hammerman-Rozenberg R, Ein-Mor E, Jacobs JM: Physical activity, function, and longevity among the very old. Arch Intern Med 2009;169:1476–1483.
  22. Fries JF: Aging, natural death and the compression of morbidity. N Engl J Med 1980;303:130–135.
  23. Stessman J, Jacobs JM, Ein Mor E, Bursztyn M: Normal Body Mass Index Rather than Obesity Predicts Greater Mortality in Elderly People: the Jerusalem Longitudinal Study. J Am Geriatr Soc. 2009;57:2232–2238.

    External Resources

  24. Moreh E, Jacobs JM, Stessman J: Fatigue, function, and mortality in older adults. J Gerontol A Biol Sci Med Sci 2010;65:887–895.

    External Resources

  25. de Ruijter W, Westendorp RG, Assendelft WJ, den Elzen WP, de Craen AJ, le Cessie S, Gussekloo J: Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study. BMJ 2009;338:a3083.
  26. Petersen LK, Christensen K, Kragstrup J: Lipid-lowering treatment to the end? A review of observational studies and RCTs on cholesterol and mortality in 80+-year olds. Age Ageing 2010;39:674–680.

    External Resources

  27. Beeri MS, Goldbourt U: Late-life dementia predicts mortality beyond established midlife risk factors. Am J Geriatr Psychiatry 2011;19:79–87.

    External Resources

  28. Zhao J, Barclay S, Farquhar M, Kinmonth AL, Brayne C, Fleming J: The oldest old in the last year of life: population-based findings from the Cambridge City over-75s cohort study participants aged 85 and older at death. J Am Geriatr Soc 2010;58:1–11.

    External Resources

  29. von Faber M, Bootsma-van der Wiel A, van Exel E, et al: Successful aging in the oldest old. Arch Intern Med 2001;161:2694–2700.
  30. Sander M, Avlund K, Lauritzen M, et al: Aging – from molecules to populations. Mech Ageing Dev 2008;129:614–623.

    External Resources

  31. Robine JM, Michel JP: Looking forward to a general theory on population aging. J Gerontol Med Sci 2004;59A:590–597.

    External Resources

  32. Fries JF: Measuring and monitoring success in compressing morbidity. Ann Intern Med 2003;139:455–459.
  33. Gill TM, Gahbauer EA, Han L, Allore HG: Trajectories of disability in the last year of life. N Engl J Med 2010;362:1173–1180.


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50